1997
Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
Buckley L, Leib E, Cartularo K, Vacek P, Cooper S. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. The Journal Of Rheumatology 1997, 24: 1489-94. PMID: 9263140.Peer-Reviewed Original ResearchConceptsBone mineral densityLow-dose methotrexateRheumatoid arthritisLumbar spineFemoral neckDose methotrexateMineral densityBMD of patientsFemoral neck bone mineral densityNeck bone mineral densitySpine bone mineral densityMeasurement of BMDAntirheumatic drug useVitamin D3 supplementationYears of followupGreater bone lossDMARD useD3 supplementationFollowup visitMTX useBone lossPrednisoneSimilar dosePatientsMethotrexate
1996
Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Buckley L, Leib E, Cartularo K, Vacek P, Cooper S. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Annals Of Internal Medicine 1996, 125: 961-8. PMID: 8967706, DOI: 10.7326/0003-4819-125-12-199612150-00004.Peer-Reviewed Original ResearchConceptsBone mineral densityLow-dose corticosteroidsPlacebo-controlled trialVitamin D3 supplementationMineral densityRheumatoid arthritisVitamin D3Prednisone therapyLumbar spineD3 supplementationBone lossOutpatient care facilitiesLong-term useCorticosteroid useVertebral fracturesWard's triangleAutoimmune diseasesFemoral neckCorticosteroidsHigh riskSupplemental calciumRational therapyPatientsArthritisTherapyPrevalence of Pulmonary Hypertension in Limited and Diffuse Scleroderma
Battle R, Davitt M, Cooper S, Buckley L, Leib E, Beglin P, Tischler M. Prevalence of Pulmonary Hypertension in Limited and Diffuse Scleroderma. CHEST Journal 1996, 110: 1515-1519. PMID: 8989070, DOI: 10.1378/chest.110.6.1515.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBlood PressureCross-Sectional StudiesEchocardiography, DopplerElectrocardiographyFemaleHumansHypertension, PulmonaryMaleMiddle AgedProspective StudiesPulmonary ArteryPulmonary Diffusing CapacityPulmonary VentilationScleroderma, SystemicTricuspid Valve InsufficiencyConceptsPulmonary artery systolic pressurePulmonary hypertensionDiffuse sclerodermaTricuspid regurgitationSignificant end-organ damageProspective cross-sectional studyTranstricuspid pressure gradientUndiagnosed pulmonary hypertensionEnd-organ damageRight atrial pressureSuccessful treatment strategyCross-sectional studyAtrial pressureMost patientsConsecutive patientsSystolic pressureDoppler echocardiogramOutpatient clinicRespiratory indexClinical signsTreatment strategiesHypertensionPatientsNoninvasive assessmentScleroderma
1995
Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis.
Buckley L, Leib E, Cartularo K, Vacek P, Cooper S. Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. The Journal Of Rheumatology 1995, 22: 1055-9. PMID: 7674230.Peer-Reviewed Original ResearchConceptsBone mineral densityRheumatoid arthritisLumbar spineFemoral neckMineral densityLow dosesLow-dose corticosteroid useLow bone mineral densitySimilar bone mineral densityLow-dose corticosteroidsMean daily doseEffect of corticosteroidsCross-sectional studyDose corticosteroidsPrednisone doseCorticosteroid useDisease durationDaily doseDaily dosesSectional studyRisk factorsStudy groupPatientsDisease severityCorticosteroids
1992
Progressive aortic valve inflammation occurring despite apparent remission of relapsing polychondritis
Buckley L, Ades P. Progressive aortic valve inflammation occurring despite apparent remission of relapsing polychondritis. Arthritis & Rheumatism 1992, 35: 812-814. PMID: 1622420, DOI: 10.1002/art.1780350716.Peer-Reviewed Original Research
1990
Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
Buckley L, Vacek P, Cooper S. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. The Journal Of Rheumatology 1990, 17: 1158-61. PMID: 2132565.Peer-Reviewed Original ResearchConceptsLow-dose methotrexateFolinic acidDose methotrexateRheumatoid arthritisShort-term side effectsDose of methotrexateIncidence of stomatitisFolinic acid supplementationTerm side effectsLeucovorin treatmentAntiarthritic effectsGastrointestinal toxicityMTX administrationCrossover trialTherapeutic effectAcid supplementationSide effectsMethotrexateLeucovorinArthritisSignificant differencesPatientsAdministrationDosePlaceboEducational and psychosocial needs of patients with chronic disease: A survey of preferences of patients with rheumatoid arthritis
Buckley L, Vacek P, Cooper S. Educational and psychosocial needs of patients with chronic disease: A survey of preferences of patients with rheumatoid arthritis. Arthritis & Rheumatism 1990, 3: 5-10. PMID: 2285739, DOI: 10.1002/art.1790030103.Peer-Reviewed Original ResearchEducational and psychosocial needs of patients with chronic disease: A survey of preferences of patients with rheumatoid arthritis
Buckley L, Vacek P, Cooper S. Educational and psychosocial needs of patients with chronic disease: A survey of preferences of patients with rheumatoid arthritis. Arthritis Care & Research 1990, 3: 5-10. DOI: 10.1002/1529-0131(199003)3:1<5::aid-anr1790030103>3.0.co;2-7.Peer-Reviewed Original Research